Skip to main content
letter
. 2016 May 3;30(8):1313–1315. doi: 10.1097/QAD.0000000000001055

Fig. 1.

Serum dolutegravir levels pre and postdose in 1st trimester (13 weeks of gestation) and 3rd trimester (32 weeks of gestation).

Fig. 1

DTG = dolutegravir, q.d. = once-daily, b.i.d. = twice-daily, IC90 = inhibitory concentration for 90% of viral growth. Dolutegravir concentrations were measured by liquid chromatography with tandem mass spectrometry after resolving the glucuronidated dolutegravir from parent compound.